AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (August 25, 2005). doi:10.1152/ajpregu.00448.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/R50    most recent
00448.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S.
Right arrow Articles by Sandberg, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.
Right arrow Articles by Sandberg, K.
Submitted on June 27, 2005
Accepted on August 16, 2005

TRANSLATIONAL REGULATION OF ANGIOTENSIN II TYPE 1 RECEPTORS IN PROLIFERATING VASCULAR SMOOTH MUSCLE CELLS

Sunghou Lee1, Hong Ji1, Zheng Wu1, Wei Zheng2, Ali Hassan2, and Kathryn Sandberg3*

1 Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC, USA
2 Department of Medicine, Georgetown University Medical Center, Washington, DC, USA
3 Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC, USA; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA

* To whom correspondence should be addressed. E-mail: sandberg{at}georgetown.edu.

The current study examined angiotensin receptor (ATR) regulation in proliferating rat aortic vascular smooth muscle cells (VSMC) in culture. Radioligand competition analysis coupled with RNase protection assays (RPA) revealed that AT1aR densities (Bmax) increased by 30% between 5 and 7 days in culture [Bmax (fmol/mg protein): day 5, 379 ± 8.4 vs day 7, 481 ± 12, n=3, P<0.05] under conditions in which no significant changes in AT1aR mRNA expression occurred [in RPA arbitrary units (AU): day 5, 0.23 ± 0.01 vs day 7, 0.24 ± 0.04, n=4] or in mRNA systhesis determined by nuclear run on assays [AU: day 5, 0.35 ± 0.14 vs day 7, 0.33 ± 0.11, n=5]. In contrast, polysome distribution analysis indicated that AT1aR mRNA was more efficiently translated in day 7 cells compared to day 5 [% of AT1aR mRNA in fraction 2 out of total AT1R mRNA recovered from the sucrose gradient: day 5, 20.9 ± 9.9 vs day 7, 56.8 ± 5.6, n=3, P<0.001]. Accompanying the polysome shift was 50% less RNA-protein complex (RPC) formation between VSMC cytosolic RNA binding proteins in day 7 cells compared to 5 day cultures and the 5' leader sequence (5'LS) of the AT1aR [5'LS RPC (AU): day 5, 0.62 ± 0.15 vs day 7, 0.23 ± 0.03; n=4, P<0.05] and also with exon 2 [Exon 2 RPC (AU): day 5, 35.0 ± 5.7 vs day 7, 17.2 ± 3.6; n=4, P<0.05]. Taken together, these results suggest that AT1aR expression is regulated by translation during VSMC proliferation in part by RNA binding proteins that interact within exon 2 in the 5'LS of the AT1aR mRNA.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox
Special feature: cardiovascular-kidney interactions in health and disease
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R34 - R36.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.